{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T13:09:11Z","timestamp":1779973751058,"version":"3.53.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UM1TR004360"],"award-info":[{"award-number":["UM1TR004360"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["5T32 HL149645-05"],"award-info":[{"award-number":["5T32 HL149645-05"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.amjcard.2026.03.050","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:12:36Z","timestamp":1774627956000},"page":"10-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Social Determinants of Health and Outcomes in Transthyretin Amyloid Cardiomyopathy"],"prefix":"10.1016","volume":"269","author":[{"given":"Adarsh","family":"Mallepally","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Slivnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyur B.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3891-7004","authenticated-orcid":false,"given":"Cory R.","family":"Trankle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2026.03.050_bib0001","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM199709253371306","article-title":"The systemic amyloidoses","volume":"337","author":"Falk","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0002","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis","volume":"81","author":"Kittleson","year":"2023","journal-title":"JACC"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0003","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.jacc.2006.01.042","article-title":"Transthyretin V122I in African Americans with congestive heart failure","volume":"47","author":"Buxbaum","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0004","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ahj.2010.02.006","article-title":"Significance of the amyloidogenic transthyretin Val 122 ile allele in African Americans in the arteriosclerosis risk in Communities (ARIC) and Cardiovascular Health (CHS) studies","volume":"159","author":"Buxbaum","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa1404852","article-title":"The amyloidogenic V122I transthyretin variant in elderly black Americans","volume":"372","author":"Quarta","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0006","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2019.17935","article-title":"Association of the V122I hereditary transthyretin amyloidosis genetic variant with heart failure among individuals of African or Hispanic\/Latino ancestry","volume":"322","author":"Damrauer","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0007","article-title":"Prevalence and outcomes of p.Val142Ile TTR amyloidosis cardiomyopathy: a systematic review","volume":"14","author":"Chandrashekar","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0008","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0009","article-title":"Transthyretin cardiac amyloidosis in black Americans","volume":"9","author":"Shah","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0010","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/jama.2022.2360","article-title":"Heart failure, precision medicine, and incremental equity: the case of hereditary amyloid cardiomyopathy","volume":"327","author":"Echols","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0011","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1001\/jama.2024.2868","article-title":"Addressing health disparities: the case for variant transthyretin cardiac amyloidosis grows stronger","volume":"331","author":"Maurer","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0012","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ahj.2009.08.006","article-title":"Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis","volume":"158","author":"Connors","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0013","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jama.2024.0442","article-title":"Cardiac amyloidosis due to transthyretin protein: a review","volume":"331","author":"Ruberg","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0014","series-title":"Social determinants of health discussion paper 2 (policy and practice)","article-title":"A conceptual framework for action on the social determinants of health","author":"Solar","year":"2010"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0015","unstructured":"Anon. Healthy People 2030, U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Available at: https:\/\/health.gov\/healthypeople\/objectives-and-data\/social-determinants-health. Accessed January 13, 2026."},{"key":"10.1016\/j.amjcard.2026.03.050_bib0016","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/jamacardio.2018.2093","article-title":"Geographic disparities in reported US amyloidosis mortality from 1979 to 2015: potential underdetection of cardiac amyloidosis","volume":"3","author":"Alexander","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0017","first-page":"454","article-title":"Race and socioeconomic status impact diagnosis and clinical outcomes in transthyretin cardiac amyloidosis","volume":"6","author":"Shankar","year":"2024","journal-title":"JACC"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0018","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.amjcard.2021.11.048","article-title":"Temporal trends in diagnostic testing patterns for wild-type transthyretin amyloid cardiomyopathy in the Medicare fee-for-service population","volume":"167","author":"Bourque","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0019","article-title":"Epidemiology of cardiac amyloidosis: associated heart failure hospitalizations among fee-for-service Medicare beneficiaries in the United States","volume":"12","author":"Gilstrap","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0020","first-page":"530","article-title":"The impact of social determinants of health on timely detection in transthyretin cardiac amyloidosis","volume":"13","author":"Fahed","year":"2025","journal-title":"JACC"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0021","first-page":"533","article-title":"Socioeconomic and geographic disparities in the reported U.S. Amyloidosis mortality from 2018 to 2022","volume":"13","author":"Fahed","year":"2025","journal-title":"JACC"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0022","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11886-025-02220-z","article-title":"Race, genetics, and social determinants of health in transthyretin cardiac amyloidosis: a literature review and call to action","volume":"27","author":"Fahed","year":"2025","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0023","unstructured":"Anon. TriNetX Research Platform. Available at: https:\/\/trinetx.com. Accessed December 18, 2024."},{"key":"10.1016\/j.amjcard.2026.03.050_bib0024","doi-asserted-by":"crossref","first-page":"ooad035","DOI":"10.1093\/jamiaopen\/ooad035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0025","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0026","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1176\/appi.ps.20240148","article-title":"Use of ICD-10-CM codes for adverse social determinants of health across health systems","volume":"76","author":"Llamocca","year":"2025","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0027","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1056\/NEJM199702133360703","article-title":"Variant-sequence transthyretin (Isoleucine 122) in late-onset cardiac amyloidosis in black Americans","volume":"336","author":"Jacobson","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0028","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/13506129.2015.1051219","article-title":"Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African\u2013Americans","volume":"22","author":"Jacobson","year":"2015","journal-title":"Amyloid"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0029","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.amjcard.2023.11.037","article-title":"A real-world analysis of new-onset heart failure after anterior wall ST-elevation acute myocardial infarction in the United States","volume":"211","author":"Van Tassell","year":"2024","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.9305","article-title":"Comparative outcomes of Empagliflozin to Dapagliflozin in patients with heart failure","volume":"7","author":"Modzelewski","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0031","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.amjmed.2025.02.010","article-title":"Sodium-glucose cotransporter 2 inhibitors in patients with amyloidosis with or without heart failure","volume":"138","author":"Augusto","year":"2025","journal-title":"Am J Med"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0032","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.amjms.2022.12.009","article-title":"Ethnic\/racial differences in risk factors and clinical outcomes among patients with amyloidosis","volume":"365","author":"Ream","year":"2023","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0033","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jama.2021.15187","article-title":"Trends in cardiovascular risk factors in US adults by race and ethnicity and socioeconomic status, 1999-2018","volume":"326","author":"He","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0034","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMsa2408259","article-title":"Association between Wealth and mortality in the United States and Europe","volume":"392","author":"Machado","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0035","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1016\/j.jacc.2019.02.042","article-title":"Disparities in cardiovascular mortality related to heart failure in the United States","volume":"73","author":"Glynn","year":"2019","journal-title":"JACC"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0036","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12170-021-00670-y","article-title":"Racial and ethnic disparities in transthyretin cardiac amyloidosis","volume":"15","author":"Spencer-Bonilla","year":"2021","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0037","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s44263-023-00016-3","article-title":"Uneven burden of cardiac amyloidosis in people of African descent: global imbalance in resources and access","volume":"1","author":"Madu","year":"2023","journal-title":"BMC Global Public Health"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0038","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ejhf.3088","article-title":"Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: distinct from wild-type transthyretin amyloidosis?","volume":"26","author":"Razvi","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0039","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1001\/jama.2024.4467","article-title":"Cardiovascular burden of the V142I transthyretin variant","volume":"331","author":"Selvaraj","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0040","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1001\/jama.2023.18688","article-title":"Eplontersen for hereditary transthyretin amyloidosis with polyneuropathy","volume":"330","author":"Coelho","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0041","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ejhf.2776","article-title":"Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy","volume":"25","author":"Porcari","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0042","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/1573403X11666141122220003","article-title":"Disparities in cardiovascular disease risk in the United States","volume":"11","author":"Graham","year":"2015","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0043","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1161\/HYPERTENSIONAHA.121.17570","article-title":"Racial\/ethnic disparities in hypertension prevalence, awareness, treatment, and control in the United States, 2013 to 2018","volume":"78","author":"Aggarwal","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0044","first-page":"460","article-title":"Health and racial disparities in diabetes mellitus prevalence, management, policies, and outcomes in the United States","volume":"8","author":"Yedjou","year":"2024","journal-title":"J Commun Med Public Health"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0045","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jacc.2025.06.008","article-title":"Update to the JACC report card: excess cardiovascular mortality among Black Americans, 2000\u20132023","volume":"86","author":"Arun","year":"2025","journal-title":"JACC"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0046","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023895","article-title":"Navigating the complex web of prescribing amyloidosis therapeutics: a primer","volume":"11","author":"Chen","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0047","article-title":"Socioeconomic disparities are associated with delayed access to tafamidis in transthyretin cardiac amyloidosis","volume":"17","author":"Miller","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0048","first-page":"qxad086","article-title":"Hospital use of common Z-codes for Medicare fee-for-service beneficiaries, 2017\u20132021","volume":"2","author":"Chang","year":"2023","journal-title":"Health Aff Sch"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0049","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/1475-6773.14039","article-title":"The adoption of social determinants of health documentation in clinical settings","volume":"58","author":"Kepper","year":"2023","journal-title":"Health Serv Res"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0050","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/jalm\/jfaa212","article-title":"Accuracy in measuring racial disparities during the COVID-19 pandemic needs improvement","volume":"6","author":"Patel","year":"2021","journal-title":"J Appl Lab Med"},{"key":"10.1016\/j.amjcard.2026.03.050_bib0051","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1007\/s40615-022-01445-w","article-title":"Discrepancies in race and ethnicity in the electronic health record compared to self-report","volume":"10","author":"Samalik","year":"2023","journal-title":"J Racial Ethn Health Disparities"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926001839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914926001839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T12:17:53Z","timestamp":1779970673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914926001839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":51,"alternative-id":["S0002914926001839"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.03.050","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Social Determinants of Health and Outcomes in Transthyretin Amyloid Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2026.03.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}